PTC Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 1K
- Market Cap
- $2.7B
- Website
- http://www.ptcbio.com
- Introduction
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
A Study of Ataluren in Pediatric Participants With Cystic Fibrosis
- First Posted Date
- 2007-04-10
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT00458341
- Locations
- 🇧🇪
Reine Fabiola Hospital, Brussels, Belgium
🇫🇷Hopital Necker Enfants Malades, Paris, France
🇧🇪UZ Gasthuisberg Leuven, Leuven, Belgium
PTC124 for the Treatment of Cystic Fibrosis
- First Posted Date
- 2006-07-12
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 19
- Registration Number
- NCT00351078
- Locations
- 🇮🇱
Hadassah University Hospital - Mount Scopus, Jerusalem, Israel
Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
- Conditions
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 38
- Registration Number
- NCT00264888
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT00237380
- Locations
- 🇮🇱
Hadassah University Hospital - Mount Scopus, Jerusalem, Israel
PTC124 for Cystic Fibrosis
- Conditions
- First Posted Date
- 2005-10-07
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT00234663
- Locations
- 🇺🇸
Stanford University Medical Center, Palo Alto, California, United States
🇺🇸Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
🇺🇸University of Alabama at Birmingham, Birmingham, Alabama, United States